The	O
DEK	O
Oncoprotein	O
Is	O
a	O
Critical	O
Component	O
of	O
the	O
EKLF	B-ENHANCER
/	I-ENHANCER
KLF1	I-ENHANCER
Enhancer	E-ENHANCER
in	O
Erythroid	O
Cells	O
.	O


Understanding	O
how	O
transcriptional	O
regulators	O
are	O
themselves	O
controlled	O
is	O
important	O
in	O
attaining	O
a	O
complete	O
picture	O
of	O
the	O
intracellular	O
effects	O
that	O
follow	O
signaling	O
cascades	O
during	O
early	O
development	O
and	O
cell	O
-	O
restricted	O
differentiation	O
.	O


We	O
have	O
addressed	O
this	O
issue	O
by	O
focusing	O
on	O
the	O
regulation	O
of	O
EKLF	O
/	O
KLF1	O
,	O
a	O
zinc	O
finger	O
transcription	O
factor	O
that	O
plays	O
a	O
necessary	O
role	O
in	O
the	O
global	O
regulation	O
of	O
erythroid	O
gene	O
expression	O
.	O


Using	O
biochemical	O
affinity	O
purification	O
,	O
we	O
have	O
identified	O
the	O
DEK	O
oncoprotein	O
as	O
a	O
critical	O
factor	O
that	O
interacts	O
with	O
an	O
essential	O
upstream	B-ENHANCER
enhancer	I-ENHANCER
element	I-ENHANCER
of	I-ENHANCER
the	I-ENHANCER
EKLF	I-ENHANCER
promoter	E-ENHANCER
and	O
exerts	O
a	O
positive	O
effect	O
on	O
EKLF	O
levels	O
.	O


This	O
element	S-ENHANCER
also	O
binds	O
a	O
core	O
set	O
of	O
erythroid	O
transcription	O
factors	O
,	O
suggesting	O
that	O
DEK	O
is	O
part	O
of	O
a	O
tissue	B-ENHANCER
-	I-ENHANCER
restricted	I-ENHANCER
enhanceosome	E-ENHANCER
that	O
contains	O
BMP4	O
-	O
dependent	O
and	O
-	O
independent	O
components	O
.	O


Together	O
with	O
local	O
enrichment	O
of	O
properly	O
coded	O
histones	O
and	O
an	O
open	O
chromatin	O
domain	O
,	O
optimal	O
transcriptional	O
activation	O
of	O
the	O
EKLF	O
locus	O
can	O
be	O
established	O
.	O
